TransMedics Group Inc (TMDX)
Profitability ratios
Return on sales
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 59.34% | 60.71% | 62.40% | 63.77% | 66.14% | 69.05% | 68.78% | 69.84% | 71.85% | 72.34% | 72.79% | 69.92% | 67.33% | 67.68% | 65.92% | 64.88% | 64.60% | 60.89% | 61.04% | 58.73% |
| Operating profit margin | 7.84% | -0.22% | -4.79% | -11.89% | -19.87% | -10.14% | -20.28% | -33.64% | -50.15% | -81.97% | -108.19% | -130.29% | -120.46% | -89.78% | -98.86% | -102.91% | -121.24% | -131.56% | -119.65% | -125.42% |
| Pretax margin | 8.51% | 0.83% | -3.43% | -10.42% | -19.36% | -11.66% | -23.62% | -38.59% | -79.74% | -122.01% | -158.41% | -195.89% | -134.16% | -100.16% | -110.56% | -112.13% | -131.38% | -143.94% | -134.19% | -142.12% |
| Net profit margin | 8.14% | 0.84% | -3.43% | -10.36% | -18.65% | -11.77% | -23.76% | -38.77% | -58.78% | -92.76% | -119.88% | -146.11% | -134.15% | -100.14% | -110.54% | -112.13% | -131.35% | -143.93% | -134.19% | -142.12% |
TransMedics Group Inc's profitability ratios have displayed varying trends over the past few quarters. The gross profit margin has generally been decreasing, indicating a decline in the percentage of revenue retained after accounting for the cost of goods sold.
The operating profit margin has been fluctuating significantly, with negative margins in several recent periods. This suggests that the company's operating expenses have been relatively high compared to its revenue, resulting in operating losses in some quarters.
Similarly, the pretax margin and net profit margin have also shown inconsistencies, with several quarters reporting negative margins. This implies challenges in generating profits after accounting for expenses and taxes.
Overall, TransMedics Group Inc's profitability ratios reflect a mixed performance with notable decreases in margins, indicating potential efficiency and cost management issues that may require further analysis and strategic adjustments to drive profitability in the future.
Return on investment
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 4.00% | -0.11% | -1.96% | -4.07% | -5.53% | -2.22% | -8.41% | -11.34% | -13.09% | -35.95% | -34.10% | -29.23% | -25.92% | -19.13% | -17.06% | -17.35% | -18.32% | -19.50% | -32.66% | -28.11% |
| Return on assets (ROA) | 4.15% | 0.40% | -1.41% | -3.54% | -5.19% | -2.58% | -9.86% | -13.07% | -15.34% | -40.68% | -37.79% | -32.78% | -28.87% | -21.34% | -19.08% | -18.91% | -19.84% | -21.34% | -36.63% | -31.86% |
| Return on total capital | 4.38% | -0.12% | -2.13% | -4.46% | -6.03% | -2.36% | -9.61% | -12.78% | -14.60% | -48.79% | -44.40% | -38.26% | -29.92% | -21.70% | -18.78% | -19.04% | -20.25% | -21.47% | -39.11% | -33.34% |
| Return on equity (ROE) | 15.55% | 1.58% | -6.39% | -18.24% | -28.29% | -12.25% | -14.69% | -19.34% | -22.45% | -93.71% | -78.22% | -65.16% | -48.20% | -33.70% | -28.48% | -27.67% | -28.86% | -30.60% | -76.05% | -61.39% |
TransMedics Group Inc's profitability ratios have shown fluctuating trends over the past few periods.
1. Operating return on assets (Operating ROA) has improved in the most recent period, indicating that the company has been more efficient in generating operating income from its assets.
2. Return on assets (ROA) also shows improvement in the latest period, suggesting better overall profitability relative to the total assets employed.
3. Return on total capital has fluctuated, but the latest period shows a slight improvement, indicating that the company is generating better returns relative to its total invested capital.
4. Return on equity (ROE) has also demonstrated variability but has shown improvement in the most recent period, indicating a more favorable return on shareholders' equity.
Overall, although there are fluctuations in the profitability ratios, there are signs of improvement in the most recent period, indicating potential operational and financial performance enhancements. It will be important to monitor these metrics consistently to assess the company's ongoing profitability and efficiency levels.